NYSE:PFE
Pfizer Inc.
Pfizer Inc.'s revenue fell 1.6% in fiscal 2025 to $62.6B. Free cash flow was $9.1B, 14.5% of revenue.Summary generated from Pfizer Inc.'s SEC filings. Latest annual report filed Feb 26, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$62.6B
Revenue growth−1.6%
Revenue, 5-yr CAGR+8.5%
Gross margin74.3%
Operating marginn/a
Net margin12.4%
ROICn/a
Return on equity8.9%
Debt / equity0.75
Free cash flow$9.1B
FCF margin14.5%
Share count change+0.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 81.3 | 101.2 | 59.6 | 63.6 | 62.6 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 22.0 | 31.4 | 2.1 | 8.0 | 7.8 |
| Free cash flow | 29.9 | 26.0 | 4.8 | 9.8 | 9.1 |
Recent filings
- 4Insider transaction report
Oct 1, 2026 - 4Insider transaction report
Sep 29, 2026 - 10-QQuarterly report for the period ended Jun 28, 2026
Aug 4, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KRegulation FD disclosure
Jun 18, 2026 - 8-KDirector or officer change
Jun 18, 2026 - 10-QQuarterly report for the period ended Mar 29, 2026
May 5, 2026 - 8-KResults of operations and financial condition
May 5, 2026